| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Pregnancy Research Branch, National Institute of Child Health and Human Development, National Institutes of Health Bethesda, Maryland 20205
Address requests for reprints to: Robert L. Collins, M.D., Department of Gynecology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, Ohio, 44106.
Preovulatory ovarian secretion of progesterone (P4), several hours before the onset of the typical midcycle gonadotropin surge, occurs in humans and monkeys. We investigated the potentially obligatory role of preovulatory P4 secretion in stimulating the midcycle LH surge by administering a potent P4 antagonist, RU 486(17β-hgydroxy-lllβ-[4-dimethylaminophenyl-l]17
[prop-l-ynyl]estra-4,9-dien-3-one), to sexually mature, normally ovulatory cynomolgus monkeys on days 10–12 of the menstrual cycle (n = 18). Monkeys were randomized to receive 1) RU 486 alone (5 mg/day, im; group I); 2) RU 486 plus dexamethasone (1 mg/day, im; group II); 3) dexamethasone alone (group III); or 4) vehicle (ethanol; 0.5 ml; group IV). Before drug treatment, the follicular phases were quite similar among groups. The administration of RU 486 blocked (delayed) the expected gonadotropin surge, despite rising estrogen concentrations (>250 pg/ml). The expected LH surge was delayed by RU 486 (n = 5) or RU 486 with dexamethasone (n = 3) until 36 ± 7 (±SEM) and 27 ± 8 days in groups I and II, respectively. In contrast, groups III (n = 3) and IV (n = 5) had timely midcycle surges after the administration of dexamethasone or vehicle alone (4 ± 2 and 6 ± 2 days, respectively). The intermenstrual interval was lengthened by RU 486 administration in both group I and II animals (61 ± 6 and 54 ± 6 days) compared to controls (30 ± 2; P < 0.0001). In summary, RU 486 effectively blocked imminent midcycle gonadotropin surges, delayed subsequent folliculogenesis, and significantly extended the menstrual cycle length. If RU 486 acted as a pure P4 antagonist, then P4 is necessary for timely midcycle gonadotropin surges to occur. However, recent evidence showing agonistic properties of RU 486 (in the virtual absence of P4) at both endometrial and pituitary levels may favor a P4-like (agonistic) blockade of the estrogen-induced FSH/LH surges by RU 486. (J Clin Endocrinol Metab63: 1270, 1986)
* Presented in part at the Seventh International Congress of Endocrinology, Quebec, Canada, July 1–7,1984
Scientific Director, Jones Institute for Reproductive Medicine, Department of Obstetrics and Gynecology, Eastern Virginia Medical School, Lewis Hall, Room 2011, Norfolk, Virginia 23501.
Received April 21, 1986.
This article has been cited by other articles:
 |
|
 |
|
  A. Gordon, R. Aguilar, J. C. Garrido-Gracia, S. Guil-Luna, R. Sanchez-Cespedes, Y. Millan, J. Martin de las Mulas, and J. E. Sanchez-Criado Activation of estrogen receptor-{alpha} induces gonadotroph progesterone receptor expression and action differently in young and middle-aged ovariectomized rats Hum. Reprod., October 1, 2009; 24(10): 2618 - 2628. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Han, S. Y. Tsai, M.-J. Tsai, and B. W. O'Malley Distinct Temporal and Spatial Activities of RU486 on Progesterone Receptor Function in Reproductive Organs of Ovariectomized Mice Endocrinology, May 1, 2007; 148(5): 2471 - 2486. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Foecking, M. Szabo, N. B. Schwartz, and J. E. Levine Neuroendocrine Consequences of Prenatal Androgen Exposure in the Female Rat: Absence of Luteinizing Hormone Surges, Suppression of Progesterone Receptor Gene Expression, and Acceleration of the Gonadotropin-Releasing Hormone Pulse Generator Biol Reprod, June 1, 2005; 72(6): 1475 - 1483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Leminen, T. Raivio, S. Ranta, J. Oehler, H. von Hertzen, O. A Janne, and O. Heikinheimo Late follicular phase administration of mifepristone suppresses circulating leptin and FSH - mechanism(s) of action in emergency contraception? Eur. J. Endocrinol., March 1, 2005; 152(3): 411 - 418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. De Geyter, M. De Geyter, P. R. Huber, E. Nieschlag, and W. Holzgreve Progesterone serum levels during the follicular phase of the menstrual cycle originate from the crosstalk between the ovaries and the adrenal cortex Hum. Reprod., April 1, 2002; 17(4): 933 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O.D. Slayden, K. Chwalisz, and R.M. Brenner Reversible suppression of menstruation with progesterone antagonists in rhesus macaques Hum. Reprod., August 1, 2001; 16(8): 1562 - 1574. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mizuno, M. Gearing, and E. Terasawa The Role of Neuropeptide Y in the Progesterone-Induced Luteinizing Hormone-Releasing Hormone Surge in Vivo in Ovariectomized Female Rhesus Monkeys Endocrinology, May 1, 2000; 141(5): 1772 - 1779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. McCracken, E. E. Custer, and J. C. Lamsa Luteolysis: A Neuroendocrine-Mediated Event Physiol Rev, April 1, 1999; 79(2): 263 - 323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Chappell, J. P. Lydon, O. M. Conneely, B. W. O' Malley, and J. E. Levine Endocrine Defects in Mice Carrying a Null Mutation for the Progesterone Receptor Gene Endocrinology, October 1, 1997; 138(10): 4147 - 4152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Xiao, L. Xia-Zhang, D. Shanen, and M. Ferin Tonic Support of Luteinizing Hormone Secretion by Adrenal Progesterone in the Ovariectomized Monkey Replaced with Midfollicular Phase Levels of Estradiol J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2233 - 2238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Baulieu Contragestion and other clinical applications of RU 486, an antiprogesterone at the receptor Science, September 22, 1989; 245(4924): 1351 - 1357. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
